News
FDA approves Ozempic to reduce risk of worsening kidney disease and cardiovascular death in...
The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk's Ozempic to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney...
Beacon granted FDA Regenerative Medicine Advanced Therapy designation for X-linked retinitis pigmentosa treatment
The U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to ophthalmic gene therapy company Beacon Therapeutics' laru-zova (laruparetigene...
Lantheus to acquire Evergreen Theragnostics
Lantheus, the radiopharmaceutical-focused company, has announced a definitive agreement to acquire Evergreen Theragnostics, in an all-cash transaction consisting of an upfront payment of $250...
